Calamos Wealth Management LLC Sells 10,597 Shares of Danaher Corporation $DHR

Key Points

• Calamos Wealth Management LLC has reduced its Danaher Corporation holdings by 14.9%, selling 10,597 shares, and now owns a total of 60,736 shares valued at approximately $12 million.
• Danaher Corporation reported earnings of $1.80 per share for the last quarter, exceeding analysts' expectations of $1.64, and had a revenue of $5.94 billion, up 3.4% year-over-year.
• The company's quarterly dividend of $0.32 per share is set to be paid on October 31st, representing an annualized yield of 0.6% with a payout ratio of 27.23%.

Calamos Wealth Management LLC decreased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 14.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,736 shares of the conglomerate's stock after selling 10,597 shares during the period. Calamos Wealth Management LLC's holdings in Danaher were worth $11,998,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of DHR. GAMMA Investing LLC grew its position in shares of Danaher by 22.2% during the 1st quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate's stock valued at $1,871,000 after acquiring an additional 1,660 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Danaher by 4.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 207,169 shares of the conglomerate's stock valued at $42,470,000 after buying an additional 7,907 shares in the last quarter. Kingswood Wealth Advisors LLC boosted its holdings in Danaher by 1.6% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,466 shares of the conglomerate's stock worth $710,000 after buying an additional 56 shares during the period. CWA Asset Management Group LLC boosted its holdings in Danaher by 8.6% in the 1st quarter. CWA Asset Management Group LLC now owns 3,317 shares of the conglomerate's stock worth $680,000 after buying an additional 263 shares during the period. Finally, Avior Wealth Management LLC boosted its holdings in Danaher by 0.7% in the 1st quarter. Avior Wealth Management LLC now owns 13,827 shares of the conglomerate's stock worth $2,835,000 after buying an additional 100 shares during the period. Institutional investors own 79.05% of the company's stock.

Danaher Stock Down 0.8%

Shares of NYSE DHR opened at $209.14 on Friday. The firm's 50-day moving average price is $201.60 and its 200-day moving average price is $197.24. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $149.76 billion, a price-to-earnings ratio of 44.50, a P/E/G ratio of 2.98 and a beta of 0.77. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $275.51.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the company posted $1.72 EPS. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's dividend payout ratio is 27.23%.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on DHR. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Robert W. Baird upped their target price on shares of Danaher from $229.00 to $236.00 and gave the stock an "outperform" rating in a report on Wednesday. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a report on Friday, July 11th. Finally, Rothschild Redb cut Danaher from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 8th. Seventeen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $245.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.